Buy Aurobindo Pharma; target of Rs 850: Motilal Oswal News News / News 6 years ago 447 Views comments Motilal Oswal recommended buy rating on Aurobindo Pharma with a target price of Rs 850 in its research report dated July 19, 2017. Read more
News Inflation is crashing, but a rate cut by RBI at its August policy meet not a given News / News - 6 years ago
News Maharashtra govt gets HC rap for failing to initiate women safety steps News / News - 6 years ago
Comments